Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ProQR Therapeutics
company
Funding Round
Post-IPO Equity
Money Raised
0
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Eli Lilly | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jul 14, 2020 | Post-IPO Debt | $ 30M | Pontifax | Detail |
| Mar 30, 2021 | Post-IPO Equity | $ 103.50M | Detail | |
| Oct 15, 2019 | Post-IPO Equity | $ 57.50M | Detail | |
| Jan 1, 2013 | Seed | 0 | Sofinnova Partners | Detail |
| Dec 10, 2018 | Post-IPO Debt | € 4.70M | Detail | |
| Apr 1, 2014 | Series A | € 42M | Sofinnova Partners | Detail |
| Sep 5, 2018 | Post-IPO Equity | $ 104.10M | Detail | |
| Sep 19, 2014 | IPO | $ 97.50M | Detail |
